Messenger RNA (mRNA)-based therapies have gained significant
attention,
following the successful deployment of mRNA-based COVID-19 vaccines.
Compared with traditional methods of genetic modification, mRNA-based
therapies offer several advantages, including a lower risk of genetic
mutations, temporary and controlled therapeutic gene expression, and
a shorter production time, which facilitates rapid responses to emerging
health challenges. Moreover, mRNA-based therapies have shown immense
potential in treating a wide range of diseases including cancers,
immune diseases, and neurological disorders. However, the current
limitations of non-viral vectors for efficient and safe delivery of
mRNA therapies, such as low encapsulation efficiency, potential toxicity,
and limited stability, necessitate the exploration of novel strategies
to overcome these challenges and fully realize the potential of mRNA-based
therapeutics. Coacervate-based delivery systems have recently emerged
as promising strategies for enhancing mRNA delivery. Coacervates,
which are formed by the aggregation of two or more macromolecules,
have shown great potential in delivering a wide range of therapeutics
due to their ability to form a separated macromolecular-rich fluid
phase in an aqueous environment. This phase separation enables the
entrapment and protection of therapeutic agents from degradation as
well as efficient cellular uptake and controlled release. Additionally,
the natural affinity of coacervates for mRNA molecules presents an
excellent opportunity for enhancing mRNA delivery to targeted cells
and tissues, making coacervate-based delivery systems an attractive
option for mRNA-based therapies. This review highlights the limitations
of current strategies for mRNA delivery and the advantages of coacervate-based
delivery systems to enable mRNA therapeutics. Coacervates protect
mRNA from enzymatic degradation and enhance cellular uptake, leading
to sustained and controlled gene expression. Despite their promising
properties, the specific use of coacervates as mRNA delivery vehicles
remains underexplored. This review aims to provide a comprehensive
overview of coacervate-mediated delivery of mRNA, exploring the properties
and applications of different coacervating agents as well as the challenges
and optimization strategies involved in mRNA encapsulation, release,
stability, and translation via coacervate-mediated delivery. Through
a comprehensive analysis of recent advancements and recommended future
directions, our review sheds light on the promising role of coacervate-mediated
delivery for RNA therapeutics, highlighting its potential to enable
groundbreaking applications in drug delivery and gene therapy.